Tela Bio Company Insiders
| TELA Stock | USD 0.96 0.02 2.04% |
Tela Bio employs about 209 people. The company is managed by 14 executives with a total tenure of roughly 488 years, averaging almost 34.0 years of service per executive, having 14.93 employees per reported executive. Analysis of Tela Bio's management performance can provide insight into the company performance.
Tela Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.3868) % which means that it has lost $0.3868 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.7641) %, meaning that it created substantial loss on money invested by shareholders. Tela Bio's management efficiency ratios could be used to measure how well Tela Bio manages its routine affairs as well as how well it operates its assets and liabilities.Tela Bio shows a total of 44.53 Million outstanding shares. The majority of Tela Bio outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Tela Bio to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Tela Bio. Please pay attention to any change in the institutional holdings of Tela Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Tela Bio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Tela Bio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Tela Bio Workforce Comparison
Tela Bio is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 675. Tela Bio totals roughly 209 in number of employees claiming about 31% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.37. Tela Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tela Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tela Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tela Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Azarbarzin Kurt over six months ago Acquisition by Azarbarzin Kurt of 11700 shares of Tela Bio at 1. subject to Rule 16b-3 | ||
Antony Koblish over six months ago Disposition of 5772 shares by Antony Koblish of Tela Bio at 2.65 subject to Rule 16b-3 | ||
Cuca Roberto over six months ago Acquisition by Cuca Roberto of 83800 shares of Tela Bio at 2.72 subject to Rule 16b-3 | ||
Paul Talmo over six months ago Disposition of 190 shares by Paul Talmo of Tela Bio at 1.22 subject to Rule 16b-3 | ||
Colleran Lisa N over six months ago Acquisition by Colleran Lisa N of 11700 shares of Tela Bio at 1. subject to Rule 16b-3 | ||
Evans Douglas G over six months ago Acquisition by Evans Douglas G of 6200 shares of Tela Bio at 5.71 subject to Rule 16b-3 | ||
Megan Smeykal over six months ago Disposition of 423 shares by Megan Smeykal of Tela Bio at 2.72 subject to Rule 16b-3 | ||
Megan Smeykal over six months ago Disposition of 5 shares by Megan Smeykal of Tela Bio at 2.65 subject to Rule 16b-3 |
Tela Bio Notable Stakeholders
A Tela Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tela Bio often face trade-offs trying to please all of them. Tela Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tela Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeffrey Blizard | President Director | Profile | |
| Megan Smeykal | Corporate VP | Profile | |
| Taylor Ocasio | General Secretary | Profile | |
| Antony Koblish | President, Cofounder | Profile | |
| Louisa Smith | Investor Officer | Profile | |
| Skott Greenhalgh | Chief Officer | Profile | |
| Jennifer Armstrong | Senior Resources | Profile | |
| Christopher Smith | VP Sales | Profile | |
| Jim Hagen | Senior Marketing | Profile | |
| Peter Murphy | Chief Officer | Profile | |
| Roberto JD | CFO COO | Profile | |
| Gregory Firestone | Chief Officer | Profile | |
| Michael Leonard | Senior Operations | Profile | |
| Paul Talmo | Chief Officer | Profile |
About Tela Bio Management Performance
The success or failure of an entity such as Tela Bio often depends on how effective the management is. Tela Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tela management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tela management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients anatomy. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Tela Bio operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 123 people.
Please note, the presentation of Tela Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tela Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tela Bio's management manipulating its earnings.
Tela Bio Workforce Analysis
Traditionally, organizations such as Tela Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tela Bio within its industry.Tela Bio Manpower Efficiency
Return on Tela Bio Manpower
| Revenue Per Employee | 331.6K | |
| Revenue Per Executive | 5M | |
| Net Loss Per Employee | 181.1K | |
| Net Loss Per Executive | 2.7M | |
| Working Capital Per Employee | 298.9K | |
| Working Capital Per Executive | 4.5M |
Complementary Tools for Tela Stock analysis
When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |